Veeva Vault Clinical alternatives for teams that don't need the full life sciences cloud

If you don't need the full Vault stack across commercial, regulatory, and clinical, Vault Clinical on its own is a heavy commitment. WeGuide covers eCOA, eConsent, wearables, and a whitelabel participant app in one regulatory-grade platform, built for academic research, CROs, and mid-market sponsors.

No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours.

patient engagement

Used by leading research and medical institutes.

Why research teams look for a Veeva Clinical alternative

The Veeva Clinical conversation usually goes like this. A mid-market sponsor or academic CRO wants clinical trial software. They hear Vault Clinical is the modern alternative to Medidata Rave. They book a call. And they discover Vault Clinical is priced and delivered as part of Veeva's enterprise Vault platform, which assumes you already run Veeva across the rest of the organisation, or that you're willing to invest in dedicated Vault administrators to stand it up.

For a top-20 pharma sponsor that already runs Vault CRM across the commercial team, Vault QMS in quality, and Vault RIM in regulatory affairs, adding Vault Clinical makes complete sense. The integration story is real, the data flows make sense, and the Veeva relationship is already there. For sponsors who aren't running Vault anywhere else, the clinical suite becomes a significant standalone commitment with enterprise pricing attached.

The other recurring gap is patient engagement depth. MyVeeva for Patients unifies eCOA, eConsent, and virtual visits in a single app, which is a real step forward from older fragmented tools. What it doesn't have is whitelabel branding under the sponsor's own name, native wearable integration, patient registries, employee wellbeing programmes, or the continuous engagement architecture (push notifications, in-app messaging, study companion) that drives high adherence over long-duration studies. For sponsors who need the participant relationship to be the centre of the study, MyVeeva is typically a foundation rather than the full solution.

WeGuide is built for the clinical layer only. No commercial CRM, no regulated content management, no broader Vault platform. Just patient engagement and clinical trial technology, configured by the sponsor's own research team, without a Vault administrator contract.

Key differences between WeGuide and Veeva
For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move to WeGuide.
Full comparison: WeGuide vs Veeva Clinical
Functionality
Primary use case
Patient engagement platform with eCOA, eConsent, registries, telehealth
Academic survey and data collection
Primary use case
Patient engagement platform with eCOA, eConsent, wearables, registries
Clinical layer of the broader Vault life sciences cloud
Primary use case
Patient engagement platform with integrated eCOA, eConsent, wearables, registries, and wellbeing
DCT platform with eCOA, eConsent, EDC, telehealth, plus outcome measure and patient voice consulting
Primary use case
Patient engagement and clinical trial platform for mid-market sponsors, academic research, registries, DCTs
Decentralised trial delivery with virtual site services for pharma sponsors
Participant mobile app
Whitelabel iOS and Android under your brand
Mobile browser view, REDCap-branded
Business model
Pure technology
Platform plus consulting (Modus, inVibe)
Model
Technology platform only
Platform plus virtual site services
Hosting model
Managed cloud (ISO 27001, HIPAA, GDPR, 21 CFR Part 11, TGA Class I)
Self-hosted by each institution on its own servers
Target customer
Mid-market sponsors, academic CROs, digital health programmes, registries
Enterprise pharma running Vault across commercial, regulatory, quality, and clinical
Business model
Pure technology platform, no consulting scope
Platform plus consulting services (Modus Outcomes, inVibe)
Target customer
Mid-market sponsors, academic research, CROs, registries, digital health programmes
Pharma sponsors running DCTs with in home or community clinic visits
Commercial model
Managed SaaS, project-based pricing
Free, self-hosted (institutional IT required)
Whitelabel app
Yes
Thread-branded Study Companion and PatientFirst eCOA
Virtual site network
Not offered (partners with existing sites)
Proprietary Metasite mobile nurse network
Whitelabel mobile app
Yes, fully branded under your organisation
No, web view only
Configuration model
No-code programme builder, self-service by research teams
Dedicated Vault administrators, enterprise implementation projects
Target customer
Mid-market sponsors, academic research, CROs, registries, health organisations
Pharma sponsors, biotech, CROs running DCTs and hybrid trials
Delivery model
Technology platform you configure directly
Technology plus managed virtual site services (Metasite)
Wearable integration
Native Garmin, Apple Health, Google Fit
Not offered
Native EDC
Integrates with external EDCs
Native Thread EDC
Whitelabel app
Yes
Science 37-branded
eCOA and ePRO
Native with 200+ validated instrument library
Custom surveys, no validated instrument library
Typical deployment time
6 weeks (BRACE Trial: 6,000 participants across 5 countries)
Enterprise implementation cycles, typically multi-month
Device model
BYOD-first (participants' own phones)
BYOD-first with sensor and wearable integrations
Typical deployment time
6 weeks (BRACE Trial: 6,000 participants across 5 countries)
Project based, services led engagement cycles
eConsent with version control
Built in
Bolt-on, limited capability
Outcome measure consulting
Not offered
Modus Outcomes (acquired)
No-code programme builder
Yes
Services-led configuration
eConsent
Built-in with regulatory version control
Not available natively
Pricing model
Project-based, all modules included
Enterprise annual contracts, typically tied to broader Vault commitments
Whitelabel mobile app
Yes, fully branded under your organisation
Thread-branded Study Companion and PatientFirst eCOA
Pricing model
Project based, all modules included, scales to study complexity
Project based with services components bundled
200+ validated instrument library
Yes, integrated into Form Builder
Survey library exists, not validated instrument-first
Patient voice qualitative analytics
Not offered
inVibe (acquired)
Roadmap stability
Independent product roadmap
Post-eMed-acquisition shifts (2024)
Wearable integration
Native Garmin, Apple Health, Google Fit
Not available natively
Whitelabel mobile app
Yes, fully branded under your organisation
MyVeeva for Patients carries Veeva branding
eCOA instrument library
200+ validated instruments integrated into Form Builder
PatientFirst eCOA with global instrument library
eCOA and ePRO
Native with 200+ validated instrument library
eCOA and ePRO included in the DCT stack
Longitudinal engagement
Automated reminders, in-app messaging, push notifications, study companion
Email invitations, manual follow-up
eCOA and ePRO
Native with 200+ validated instrument library
MyVeeva for Patients covers eCOA and ePRO
eConsent
Built-in with regulatory version control and re-consent workflows
Integrated in platform
eConsent
Built-in with regulatory version control
Built-in with regulatory version control
Multi-language
Built-in translation management (proven on INHERIT study)
Manual translation per form
Telehealth
Built-in video visits and virtual site features
Virtual Visits as a core feature
Whitelabel mobile app
Yes, fully branded under your organisation
Science 37 branded participant experience
No-code programme builder
Yes, research teams configure studies directly
Form-level yes, but engagement and app experience require external tools
Wearable integration
Native Garmin, Apple Health, Google Fit
Supported through partner integrations
EDC
Integrates with external EDCs (Rave, Vault, REDCap, Viedoc, Clinion)
Native Thread EDC
Virtual site network (mobile nurses, community clinics)
Not offered; we coordinate with sponsor site networks
Metasite network (unique in market)
REDCap integration
Two-way sync via Integration Engine, pick up where REDCap leaves off
Native platform
Telehealth and virtual visits
Built-in video visit and virtual site features
MyVeeva for Patients covers virtual visits
Wearable integration
Native Garmin, Apple Health, Google Fit
Sensor and wearable integrations
Native wearable integration
Native Garmin, Apple Health, Google Fit
Supported through partner integrations
deployment-time
Typical 6 weeks for a full study launch
Depends on institutional IT; days for simple forms, months for custom builds
Patient registry
Built-in longitudinal registry (GenV: 100,000+ families)
Not a native use case
Patient registry
Built-in longitudinal registry capability (FSHD Global Registry)
Not a native offering
Telehealth
Built-in video visit and virtual site features
Built-in tele-visit capabilities
Regulatory certification
TGA certified Class I medical device software
Depends on each institution's hosting configuration
Employee wellbeing and population health
Built-in (Lendlease programme)
Outside the platform's scope
Employee wellbeing and population health
Built-in (Lendlease, GenV)
Not a primary use case
Patient registry
Built-in longitudinal registry (GenV: 100,000+ families)
Not a native use case
Pricing
Project-based, includes hosting, support, and all modules
Free licence, but institutional IT, server hosting, maintenance, and developer time not included
EDC
Form Builder covers eCRF use cases, deeper capture via Integration Engine
Vault EDC, a direct Medidata Rave competitor with strong Vault-customer adoption
Citizen science and multilingual community studies
Built-in (INHERIT)
Not a primary use case
Employee wellbeing and population health
Built-in (Lendlease programme)
Outside the platform's scope
Life sciences cloud breadth
Clinical and participant layer only
Full Vault platform: CRM, QMS, RIM, PromoMats, Clinical
Multi-language translation management
Built-in (INHERIT study proof)
Available in enterprise Vault
Outcome measure consulting
Not offered (technology only)
Modus Outcomes (acquired)
No-code programme builder
Yes, research teams configure studies directly
Services-led configuration
Regulatory certification
TGA Class I medical device, ISO 27001, 21 CFR Part 11, HIPAA, GDPR
21 CFR Part 11 and broad regulatory compliance across Vault
Patient voice qualitative analytics
Not offered
inVibe (acquired)
Regulatory certification
TGA Class I medical device, ISO 27001, 21 CFR Part 11, HIPAA, GDPR
21 CFR Part 11, DCT regulatory track record
Australian data residency
Yes
Regional options via Veeva global infrastructure
No-code programme builder
Yes, research teams configure studies directly
PatientFirst eCOA is no-code; broader configuration is services-led
Australian data residency
Yes
Not native
Regulatory certifications
TGA Class I, ISO 27001, 21 CFR Part 11, HIPAA, GDPR
21 CFR Part 11, HIPAA, GDPR
Ownership continuity
Independently roadmapped
Acquired by eMed in 2024
Australian data residency
Yes
Not a primary offering
Pricing model
Project-based, all modules included, technology only
Enterprise project-based, often includes consulting scope
Deployment time
Typical 6 weeks
Study-dependent, services-led timelines
Top alternatives to Veeva Clinical in 2026
Here's the shortlist of platforms most teams evaluate when they're looking at Vault Clinical, Vault EDC, or MyVeeva for Patients and want to compare real alternatives.
Alternative #1
WeGuide
A patient engagement and clinical trial platform built around the participant's mobile experience. WeGuide combines eCOA, eConsent, wearables, registries, telehealth, and analytics in a single platform with whitelabel apps under your own brand. TGA certified Class I, ISO 27001, 21 CFR Part 11, HIPAA and GDPR compliant. Strong fit for academic research institutions, CROs, and mid-market sponsors who need engagement and multi-modal data, not just surveys. Deploy timelines average six weeks.
Best For
patient engagement studies, longitudinal registries, eCOA and ePRO trials, wearable data collection, multilingual multisite studies.
Alternative #2
Oracle Life Sciences
Oracle Life Sciences empowers sponsors, contract research organizations (CROs), and research sites with a unified, interoperable platform designed to streamline the entire clinical development lifecycle. By integrating clinical trial management, data collection (EDC), randomization (RTSM), and pharmacovigilance into a single cloud-based ecosystem, Oracle eliminates data silos and secures high-fidelity information.
Best For
Global pharmaceutical companies, mid-market biotech, and CROs requiring enterprise-grade scalability, multi-site Phase II-IV trials.
Alternative #3
Medidata Rave
The gold standard for large, global, late stage pharma trials. Enterprise pricing, 3 to 6 month implementation cycles, deepest CRF library in the industry. Overkill for most teams leaving REDCap, but unmatched if you're running multi site Phase II to IV trials.
Best For
top 50 pharma sponsors and large CROs with enterprise budgets.
Alternative #4
OpenClinica
Open source EDC with a paid enterprise SaaS edition. Ranks #1 in Google for "edc clinical trials" and has 20 years of regulatory history. Thin eCOA module (Participate), no native wearables.
Best For
CROs and device companies needing deep EDC and edit check functionality at mid-market pricing.
Alternative #5
IQVIA
IQVIA's CORE clinical platform and Patient Engagement Suite are sold alongside IQVIA's CRO services, real-world data, and site network. Enterprise positioning with the services wrap built in. Different delivery model to Veeva (services-led rather than platform-led).
Best For
enterprise sponsors who want clinical trial technology bundled with CRO services.

All-in-one platform

WeGuide combines eCOA, eConsent, data collection, and telehealth in a single platform with whitelabel apps under your own brand.

eConsent

Regulatory grade electronic consent with version tracking, re-consent workflows, digital signatures, and audit trails. REDCap doesn't have native eConsent, so teams either pair it with a second vendor or manage consent on paper.
We Guide

Screening

Screen participants against eligibility criteria directly in the app before they enrol, with branching logic and automated routing to the right study arm.

Data collection

Native eCOA and ePRO with a 200+ validated instrument library, custom forms with branching logic, and multimodal capture through forms, video, active tasks, and sensors.

Telehealth

Built in video visits, asynchronous messaging, and remote assessments that keep participants engaged with their research team between site visits.

Continuous engagement, not once-off surveys

Push notifications, educational content delivery, gamification, and a study companion that guides participants through the protocol. This is the difference between collecting data when a participant remembers and collecting data on schedule because the app is genuinely useful to them. The BRACE Trial achieved 90% adherence across 6,000 participants in five countries using this architecture. See WeGuide’s patient education module →

Push notifications and reminders

Scheduled push notifications, smart reminders, and re engagement flows that meet participants where they are on their phone rather than waiting for them to check an email.
We Guide

Study companion

A dedicated study companion that explains what's coming next, why it matters, and how to complete it ensuring participants stay informed and on track throughout the entire journey.

Educational content and gamification

Contextual educational content, progress tracking, and gentle gamification that keep participants engaged across multi year longitudinal studies.

Mobile multimodal collection

Capture the full picture of a participant's experience through forms, video, pathology, and passive sensor data all in the same app.

Forms

Native eCOA and ePRO instruments with branching logic, validation, and offline support. 200+ validated instruments ready to drop into a study.
We Guide

Video

Structured video capture for symptom diaries, gait analysis, and remote clinical assessments, stored securely against the participant record.

Pathology

Seamlessly set up integrations with your pathology providers to collect DNA or blood data from participants, streamlining the clinical data pipeline directly within the study workflow.

Sensors

Native Garmin, Apple Health, Google Fit, and FindAir integrations that sync passive wearable and sensor data straight into the study database.

Whitelabel: your study, your brand

WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. The app becomes the study's home for the participant, which is a big part of why our studies average 94% adherence.

Your brand end-to-end

Native iOS and Android apps under your organisation's name, logo, and colours not a WeGuide-branded web view.
We Guide

App store distribution

Published under your developer account on the Apple App Store and Google Play so participants download an app that clearly belongs to your institution.

Multilingual out of the box.

Translation management for multisite, multi-country studies, proven on INHERIT across multilingual communities.

Where WeGuide goes further

For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move from Veeva Clinical to WeGuide.

Clinical layer only, not a life sciences platform commitment

No-code configuration without dedicated administrators

Mid-market accessibility

Whitelabel mobile apps under your own brand

Native wearable SDK

Deploy in weeks, not enterprise cycles

Patient registries and employee wellbeing

Multi-language translation management

TGA certification and Australian data residency

Built for regulated research

Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.

TGA Certified

Certified Class I medical device software under the Therapeutic Goods Administration.

ISO 27001

Certified information security management covering access, audit, and incident response.

Data Hosted in Australia

Participant data is hosted in Australian data centres with sovereign data controls.

GDPR Compliant

GDPR, HIPAA, and 21 CFR Part 11 ready for multi-country and US-based studies.

Biometric Security

Participant access protected by PIN code and biometric authentication on device.

256-bit AES Encryption

All data encrypted at rest and in transit with automated backups and disaster recovery.
12x

Faster

Your own platform ready in weeks and changes are made in minutes

94%

Adherence Rates

High patient engagement and better quality data

10x

Cost Saving

Reduce financial and technology risk when creating a secure health app

200K+

Patients Impacted

With our ease of use and roll out, our apps have engaged 200k+ users

Where Veeva excels

Veeva Systems has built one of the most substantial life sciences software platforms in the market, and an honest comparison has to acknowledge that before talking about where WeGuide fits.

Market-leading life sciences cloud. Vault is the industry standard for regulated documents and data across commercial, quality, regulatory, and clinical. For enterprise pharma that wants one platform across the entire life sciences operation, Veeva's breadth is unmatched. Vault CRM runs the commercial team, Vault QMS runs quality, Vault RIM runs regulatory affairs, Vault PromoMats runs promotional content, and Vault Clinical runs trials, all on the same regulated-document backbone with genuine cross-platform integration.

Deep Vault integration across the stack. The integration story between Vault modules is real. For Vault customers already running commercial, quality, and regulatory workflows, adding Vault Clinical means data flows into a stack their organisation already knows. That continuity is a genuine strength and not something a standalone clinical platform can replicate.

Vault EDC as a direct Rave competitor. Vault EDC has earned real market share as a modern alternative to Medidata Rave, especially for sponsors already on the Vault platform. For teams that want enterprise eCRF depth with cloud-native architecture, Vault EDC is a capable and regulator-accepted product. WeGuide does not replace Vault EDC for deep eCRF use cases.

MyVeeva for Patients unifies eCOA, eConsent, and visits. MyVeeva for Patients is a genuine step forward from older fragmented eCOA and eConsent vendors. Sponsors who want the three core participant-facing functions in one Veeva-supported app find MyVeeva a solid foundation.

Enterprise support and roadmap stability. Veeva is publicly traded with a $30B+ market cap. For enterprise sponsors whose procurement and risk teams need long-term vendor stability, Veeva's size and financial position are genuine advantages.

If your organisation already runs Vault across commercial, quality, and regulatory, adding Vault Clinical is a defensible choice and we'd rather say that honestly than pitch WeGuide into a study where Veeva's integrated stack makes more sense.

WeGuide runs alongside Veeva Vault

If your organisation already runs Vault Clinical or Vault EDC for core clinical data management, you don't have to rip it out to use WeGuide for the participant-facing layer. Our Integration Engine connects to Vault through its APIs, so Veeva handles regulated document management and core EDC while WeGuide runs whitelabel patient engagement, eCOA, eConsent, wearables, registries, and telehealth. Hybrid stacks are common with teams that want Veeva's enterprise Vault depth plus WeGuide's participant experience.

How the switch works

For teams that are evaluating Vault Clinical but want a pure patient-engagement alternative, or for Veeva Vault customers who want to layer WeGuide on top of the existing stack, here's how onboarding typically plays out.

Discovery Call

A 30-minute conversation with one of our research delivery team. We look at your protocol, your current Vault setup, and what's actually blocking you. No sales pitch.

Study Configuration

Our team works alongside yours to configure the study in WeGuide. If you're keeping Vault EDC for core data capture, we configure the Integration Engine at this stage. Typical timeline: two to four weeks.

We Guide

Participant Onboarding

The whitelabel app goes live under your organisation's brand. Research coordinators invite participants, and consent flows, eCOA instruments, and engagement templates are ready.

Ongoing Support

You get a named research delivery contact, not a Vault administrator contract. We stay involved for the life of the study.

Case studies: research teams that wanted the clinical layer, not the full Vault stack
BRACE Trial (Murdoch Children's Research Institute)

Murdoch Children's Research Institute. A global randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity. Launched across five countries with 6,000+ participants in six weeks during the pandemic. MCRI needed fast deployment and participant-facing architecture, not an enterprise Vault implementation project.

GenV (Generation Victoria)

A population health study tracking more than 100,000 Victorian families from birth. Longitudinal registry work at this scale sits outside Vault Clinical's scope. The whitelabel family-facing app is the reason retention has held across multiple years.

Lendlease wellbeing programme

An employee wellbeing deployment across a global workforce, using WeGuide for participant-reported outcomes, engagement content, and population health analytics. The kind of programme that sits entirely outside the Vault Clinical product scope and shows what a broader patient engagement platform enables.

Helping researchers transform ideas into discoveries.

Hear what our clients have to say!

"GenV trusted WeGuide to run a multi-year population health study across more than 100,000 Victorian families. Longitudinal engagement at this scale requires push notifications, multi-modal data capture, and a whitelabel app that families will keep on their phones for years.""
Susan Clifford
Susan Clifford
Senior Research Officer
GEN V logo
“The main benefit of WeGuide is its convenience. I can’t imagine how we would follow thousands of participants and collect their data without WeGuide!”
Kaya Gardiner
Kaya Gardiner
Trial Project Manager
Murdoch children Research Institute
"WeGuide has transformed how we manage our patient registry. The ease of digital screening and obtaining eConsent has significantly improved our workflow."
Emma Photo
Emma Weatherley
Managing Director
FSHD Global
"The WeGuide trial offers staff a practical tool for recording daily COVID-19 symptoms and temperatures. For those in high-risk areas, daily reminders and alerts provide peace of mind and reassurance about their health."
KATE Cranwell
Kate Cranwell
Manager
Western Health
"It’s obvious that WeGuide is committed to develop technology that benefits people in the community. WeGuide has been a great partner in achieving this goal within Western Health."
Testimonial Photo
Paul Eleftheriou
Chief Medical Officer
Western Health

Questions

Straight answers on how WeGuide compares to Science 37, what migration looks like, and when staying on Science 37 is the right call.

Contact us

Is WeGuide a full replacement for Veeva Clinical Suite?

Honestly, it depends on your Vault footprint. For top 50 pharma running full regulated clinical commercial integration across Vault CRM, Vault QMS, Vault RIM, and Vault Clinical, Veeva's platform depth is irreplaceable and we won't pretend otherwise. For mid-market sponsors, academic institutions, and CROs that only need clinical trial technology without the full Vault commercial and regulatory stack, WeGuide covers the clinical layer with whitelabel participant engagement, eCOA, eConsent, wearables, telehealth, and registries at a pace and price point that matches mid-market research.

Does WeGuide replace Vault EDC?

No, not for deep eCRF use cases. WeGuide's Form Builder covers participant reported data, eCOA instruments, and engagement workflows with a no-code interface that researchers can use directly. For complex eCRF work with deep edit checks, validation rules, and regulatory grade data capture, Vault EDC (or another dedicated EDC) is the right tool, and our Integration Engine connects to Vault EDC through its APIs so you can run both. We'll tell you honestly on the demo call whether your study needs a standalone EDC alongside WeGuide.

How does MyVeeva for Patients compare to WeGuide?

MyVeeva for Patients unifies eCOA, eConsent, and virtual visits in a single Veeva branded app, which is a real step forward from older fragmented tools. WeGuide covers the same three functions and adds whitelabel branding under your organisation's name, native wearable integration (Garmin, Apple Health, Google Fit), continuous engagement architecture (push notifications, in-app messaging, study companion), patient registries, and employee wellbeing and population health use cases that sit outside MyVeeva's scope. Different positioning for different studies.

How does pricing compare?

Veeva Vault Clinical is enterprise priced with annual contracts, typically assuming an enterprise Vault customer profile. Vault EDC, MyVeeva for Patients, and Vault CTMS are often priced as modules within the broader Vault commitment. WeGuide is project based and scales to the study's actual complexity, with every module included in the core licence. For mid-market sponsors and academic research, WeGuide is typically significantly less expensive, and the implementation cost is lower because you don't need a dedicated Vault administrator to stand up the platform.

Can WeGuide coexist with Veeva in a pharma stack?

Yes. Many of the teams we work with run Vault for core EDC, CTMS, or regulated document management and WeGuide for the participant-facing layer. Our Integration Engine connects to Vault through its APIs, so Veeva handles the core clinical data and document workflows while WeGuide runs whitelabel patient engagement, eCOA, eConsent, wearables, and registries. Hybrid architectures are common with enterprise teams that want both.

Is WeGuide 21 CFR Part 11 ready?

Yes, along with TGA Class I medical device certification, ISO 27001, HIPAA, GDPR, and CE marking. Regulatory compliance is part of the core platform, not an enterprise upgrade. For sponsors running FDA facing studies with direct submission requirements, our compliance posture covers the standard regulatory ground, and for Australian investigator-led studies the TGA certification and Australian data residency are genuine differentiators that global platforms can't match without a local hosting partner.

Compare WeGuide to other clinical trial platforms

Eleven more honest platform comparisons, from academic EDC to enterprise pharma.
Veeva Vault Clinical
Life sciences cloud
Thread Research
Virtual CRO + software
Clario
eCOA specialist
Oracle Clinical
Clinical One & InForm
OpenClinica
Open-source EDC
Medable
DCT for top-50 pharma
IQVIA
Full-service CRO
Florence Healthcare
Site-side workflow
Science 37
Open-source EDC
obviohealth
Virtual site service
Medidata Rave
Enterprise pharma stack

Never miss an update

Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.

By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.

Thank you! Your submission has been received!
Oops! Something went wrong. Please try again.

Certified and Compliant by Leading Standards